EMN
equitynet sellingEastman Chemical Co · NEW YORK STOCK EXCHANGE, INC.
Buy it with play money
Fills at the latest stored close and lands in your paper portfolio
Sign in to buy EMN with $10,000 of play money and watch it from here.
Sign in to tradePrice, and when Congress traded it
Hollow marks where they traded, filled where the filing went public
Hover a marker to see who traded and what it was worth.
If you had bought it yourself
Paid at that day's close, held ever since. No member involved.
Working it out…
Financials
As each period's own 10-K or 10-Q reported it
At the $62.69 close on Oct 9, 2026, against 115.3M shares and the balance sheet at Jun 30, 2026; earnings, sales and cash flow over the four quarters to Jun 30, 2026. A ratio is left out where its denominator is not positive. Fair value is the company's own median P/E, price to sales and price to free cash flow at its last ten fiscal year ends, applied to its trailing figures, the middle of the three: its valuation against its own past, not against its growth or its rivals.
| Line item | FY 2016 Dec 31, 2016 | FY 2017 Dec 31, 2017 | FY 2018 Dec 31, 2018 | FY 2019 Dec 31, 2019 | FY 2020 Dec 31, 2020 | FY 2021 Dec 31, 2021 | FY 2022 Dec 31, 2022 | FY 2023 Dec 31, 2023 | FY 2024 Dec 31, 2024 | FY 2025 Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9B | $9.5B | $10.2B | $9.3B | $8.5B | $10.5B | $10.6B | $9.2B | $9.4B | $8.8B |
| Gross margin | 26.1% | 25.7% | 24.4% | 24.1% | 23.3% | 23.9% | 20.2% | 22.4% | 24.4% | 21.1% |
| Operating income | $1.4B | $1.5B | — | — | — | — | — | — | — | — |
| Operating margin | 15.3% | 16.0% | — | — | — | — | — | — | — | — |
| Net income | $854M | $1.4B | $1.1B | $759M | $478M | $857M | $793M | $894M | $905M | $474M |
| Net margin | 9.5% | 14.5% | 10.6% | 8.2% | 5.6% | 8.2% | 7.5% | 9.7% | 9.7% | 5.4% |
| EPS (diluted) | $5.75 | $9.47 | $7.56 | $5.48 | $3.50 | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 |
| Operating cash flow | $1.4B | $1.7B | $1.5B | $1.5B | $1.5B | $1.6B | $975M | $1.4B | $1.3B | $970M |
| Capital spending | $626M | $649M | $528M | $425M | $383M | $555M | $611M | $828M | $599M | $546M |
| Free cash flow | $759M | $1B | $1B | $1.1B | $1.1B | $1.1B | $364M | $546M | $688M | $424M |
| Buybacks | — | — | — | — | — | $900M | — | — | — | — |
| Dividends paid | $272M | $296M | $318M | $343M | $358M | $375M | $381M | $376M | $379M | $381M |
| Cash | $181M | $191M | $226M | $204M | $564M | $459M | $493M | $548M | $837M | $566M |
| Debt | $6.3B | $6.1B | $5.9B | $5.6B | $5.3B | $4.4B | $4B | $4.3B | $4.6B | $4.2B |
| Shareholders' equity | $4.5B | $5.4B | $5.8B | $6B | $6B | $5.7B | $5.2B | $5.5B | $5.8B | $6B |
| Shares outstanding | 217.71M | 218.37M | 219.14M | 219.64M | 220.64M | 221.81M | 222.35M | 222.76M | 223.59M | 223.94M |
Figures come from the company's XBRL filings as the SEC publishes them. Quarters are worked out from year-to-date figures, and a fourth quarter is the year less its first nine months, which is why it has no EPS: per-share figures do not subtract. Earlier years are on today's share basis where a split has happened since. A later restatement is not mixed into a year it was never applied to, so where a 10-K restated the year before — a business sold, say — that year's fourth quarter is left blank rather than worked out across two bases. A dash means the company did not report that line under a standard tag for that period. Every filing on EDGAR.
Short interest
Shares sold short, as brokers report them to FINRA twice a month
| Settlement date | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 6.67M | +15.6% | 5.3 |
| Sep 15, 2026 | 5.77M | +7.0% | 5.4 |
| Aug 31, 2026 | 5.39M | -4.1% | 6.3 |
| Aug 14, 2026 | 5.62M | +6.7% | 5.7 |
| Jul 31, 2026 | 5.27M | -1.8% | 3.8 |
| Jul 15, 2026 | 5.36M | -1.9% | 4.7 |
| Jun 30, 2026 | 5.47M | -8.8% | 3.8 |
| Jun 15, 2026 | 5.99M | +8.7% | 5.9 |
Largest fails to deliver, the last year
25 settlement days with at least $10,000 of shares sold and not delivered
| Settlement date | Shares | Value |
|---|---|---|
| Jan 9, 2026 | 63.64K | $4.4M |
| Apr 6, 2026 | 48.15K | $3.6M |
| Mar 26, 2026 | 44.39K | $3.2M |
| Mar 17, 2026 | 31.03K | $2.2M |
| Mar 18, 2026 | 21.44K | $1.5M |
Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.
What they lobby on
Disclosed to the Senate, largest spend first
- EASTMAN CHEMICAL COMPANY$1.1M
Taxation/Internal Revenue Code, Environment/Superfund, Tariff (miscellaneous tariff bills), Energy/Nuclear
1st Quarter (Jan 1 - Mar 31) 2026
- EASTMAN CHEMICAL COMPANY$800K
Taxation/Internal Revenue Code, Environment/Superfund, Tariff (miscellaneous tariff bills), Energy/Nuclear
2nd Quarter (Apr 1 - June 30) 2026
- VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)$50K
Energy/Nuclear
2nd Quarter (Apr 1 - June 30) 2026
- S-3 GROUP$50K
Chemicals/Chemical Industry
2nd Quarter (Apr 1 - June 30) 2026
- RIDGELINE ADVOCACY GROUP LLC$50K
Energy/Nuclear, Environment/Superfund, Chemicals/Chemical Industry
2nd Quarter (Apr 1 - June 30) 2026
- RIDGELINE ADVOCACY GROUP LLC$50K
Energy/Nuclear, Environment/Superfund, Chemicals/Chemical Industry
1st Quarter (Jan 1 - Mar 31) 2026
- VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)$50K
Energy/Nuclear
1st Quarter (Jan 1 - Mar 31) 2026
- S-3 GROUP$50K
Chemicals/Chemical Industry
1st Quarter (Jan 1 - Mar 31) 2026
Federal contracts
Largest awards of the last two years
- Department of Energy$375M
EASTMAN CHEMICAL COMPANY · from Sep 16, 2024
More on EMN
Who traded it
Most active first
Every disclosure
10 in total, newest first
| Member | Amount |
|---|---|
| Lisa McClainMI · housesellspouse | $1K – $15K |
| Lisa McClainMI · housebuyspouse | $1K – $15K |
| Robert BresnahanPA · housesell | $1K – $15K |
| Kathy ManningNC · houseselljoint | $1K – $15K |
| Kathy ManningNC · housebuyjoint | $1K – $15K |
| John RutherfordFL · housesell | $1K – $15K |
| Peter MeijerMI · housesell | $1K – $15K |
| Dean PhillipsMN · housebuy | $1K – $15K |
| Gilbert CisnerosCA · housesell | $1K – $15K |
| John RutherfordFL · housebuy | $1K – $15K |
Follow Eastman Chemical Co (EMN) by email
New trades in Eastman Chemical Co (EMN) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.